Instrument Inactif
Secteur Ranbaxy Laboratories Limited
Actions
RANB
INE015A01028
Produits pharmaceutiques
|
Cours en clôture
NSE India S.E.
|
||
| - INR | - |
|
| 17/07/14 | Novartis : confirme l'objectif de croissance de ses ventes | RE |
| 17/07/14 | Novartis : confirme l'objectif de croissance du C.A. annuel | RE |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0,00% | - | - | - | - | - | - | - | 0 | |
| -2,33% | +0,53% | +0,03% | -3,53% | +7,67% | +51,65% | +115,42% | +400,79% | +1 341,66% | 1 031 Md | |
| -1,06% | -1,65% | -0,42% | +4,24% | +27,92% | +42,78% | +69,98% | +63,93% | +124,11% | 638 Md | |
| -0,65% | -1,32% | +2,02% | +3,95% | +14,49% | +12,98% | +75,49% | +142,50% | +314,76% | 462 Md | |
| -2,66% | -1,87% | -1,66% | +13,08% | +38,05% | +73,13% | +41,15% | +93,46% | +132,83% | 359 Md | |
| -0,56% | -4,40% | -0,03% | +5,66% | +5,85% | +23,06% | +40,05% | +0,62% | +43,73% | 335 Md | |
| -1,42% | -0,67% | -9,77% | -5,47% | +7,81% | +13,59% | +26,55% | +55,35% | +53,65% | 273 Md | |
| -1,64% | -2,60% | +0,97% | -12,82% | -12,41% | -2,88% | +10,30% | +37,67% | +139,60% | 253 Md | |
| -0,50% | +3,80% | -1,95% | +16,40% | +28,78% | +49,37% | +56,84% | +98,22% | +152,69% | 228 Md | |
| -1,47% | -1,53% | +1,85% | +17,98% | +21,44% | +34,28% | +98,89% | +113,39% | +88,38% | 185 Md | |
| -1,89% | -1,66% | -15,35% | -23,21% | -23,50% | -32,12% | -60,93% | -18,83% | +83,28% | 170 Md | |
| -0,70% | +1,21% | +0,21% | +18,44% | +14,54% | +11,93% | -14,02% | -33,69% | -15,80% | 163 Md | |
| -0,74% | +1,25% | -3,99% | +5,25% | +15,32% | +33,49% | +50,35% | +188,22% | +499,48% | 133 Md | |
| -0,73% | +2,04% | -6,60% | +8,30% | +15,68% | +38,36% | +7,51% | +5,46% | +15,73% | 127 Md | |
| -1,27% | -3,03% | -3,56% | +13,00% | +4,09% | +10,52% | +96,35% | +328,23% | +412,03% | 99,55 Md | |
| -1,27% | -3,57% | -3,29% | -6,22% | -0,80% | +8,28% | +21,97% | +4,50% | -13,03% | 97,46 Md | |
| +0,63% | +1,40% | -4,88% | +0,08% | -11,62% | -14,17% | -28,20% | -11,50% | +7,14% | 98,83 Md | |
| -5,35% | +5,74% | +37,22% | +174,98% | +553,00% | +645,53% | +86,44% | -49,96% | - | 76,88 Md | |
| +1,03% | -5,43% | -5,11% | +21,61% | -1,76% | +34,86% | -7,86% | +25,30% | +88,61% | 75,72 Md | |
| -1,57% | +1,57% | -2,65% | -5,85% | +10,97% | +12,95% | -11,94% | -25,66% | +41,06% | 68,18 Md | |
| Moyenne | -0,71% | +0,05% | -0,89% | +12,94% | +37,66% | +55,14% | +35,49% | +74,63% | +195,00% | 243,66 Md | |
| Moyenne pondérée par Capi. | -0,98% | -0,14% | -1,08% | +5,33% | +20,98% | +41,14% | +56,84% | +136,87% | +396,46% |
- Bourse
- Actions
- Action RANB
- Secteur Ranbaxy Laboratories Limited
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
